Unexplained Anemia in the Elderly

Seminars in Hematology

Volumn 45, Issue 4, 2008, Pages 250-254

  Makipour, Sasan ^a   Kanapuru, Bindu ^a   Ershler, William B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYANOCOBALAMIN; ERYTHROPOIETIN; FOLIC ACID; GAMMA INTERFERON; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; IRON; RECOMBINANT ERYTHROPOIETIN; THYROTROPIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANDROGEN DEFICIENCY; ANEMIA; ARTICLE; CELL AGING; CELL FUNCTION; CELL PROLIFERATION; CHRONIC INFLAMMATION; CREATININE CLEARANCE; CYTOKINE PRODUCTION; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROPOIETIN DEFICIENCY; FOLIC ACID BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HORMONE DEFICIENCY; HUMAN; IDIOPATHIC DISEASE; IRON BINDING CAPACITY; IRON BLOOD LEVEL; KIDNEY FAILURE; MEAN CORPUSCULAR VOLUME; MYELODYSPLASIA; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; QUALITY OF LIFE; STEM CELL; TESTOSTERONE BLOOD LEVEL; THROMBOCYTE COUNT; THYROTROPIN BLOOD LEVEL; UNEXPLAINED ANEMIA; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGING; ANDROGENS; ANEMIA; CELL AGING; CYTOKINES; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; HEMATOPOIETIC STEM CELLS; HUMANS; INFLAMMATION; RENAL INSUFFICIENCY;

EID: 52049117644     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2008.06.003     Document Type: Article

References (57)

1. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., Klein H.G., and Woodman R.C. Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia. Blood 104 (2004) 2263-2268
2. Ania B.J., Suman V.J., Fairbanks V.F., Rademacher D.M., and Melton III L.J. Incidence of anemia in older people: An epidemiologic study in a well defined population. J Am Geriatr Soc 45 (1997) 825-831
3. Nissenson A.R., Goodnough L.T., and Dubois R.W. Anemia: Not just an innocent bystander?. Arch Intern Med 163 (2003) 1400-1404
4. Penninx B.W., Guralnik J.M., Onder G., Ferrucci L., Wallace R.B., and Pahor M. Anemia and decline in physical performance among older persons. Am J Med 115 (2003) 104-110
5. Penninx B.W., Pahor M., Cesari M., Corsi A.M., Woodman R.C., Bandinelli S., et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 52 (2004) 719-724
6. Penninx B.W., Pluijm S.M., Lips P., Woodman R., Miedema K., Guralnik J.M., et al. Late-life anemia is associated with increased risk of recurrent falls. J Am Geriatr Soc 53 (2005) 2106-2111
7. Chaves P.H., Ashar B., Guralnik J.M., and Fried L.P. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated?. J Am Geriatr Soc 50 (2002) 1257-1264
8. Izaks G.J., Westendorp R.G., and Knook D.L. The definition of anemia in older persons. JAMA 281 (1999) 1714-1717
9. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
10. Chaves P.H., Xue Q.L., Guralnik J.M., Ferrucci L., Volpato S., and Fried L.P. What constitutes normal hemoglobin concentration in community-dwelling disabled older women?. J Am Geriatr Soc 52 (2004) 1811-1816
11. Wu W.C., Schifftner T.L., Henderson W.G., Eaton C.B., Poses R.M., Uttley G., et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 297 (2007) 2481-2488
12. Baylis C., and Schmidt R. The aging glomerulus. Semin Nephrol 16 (1996) 265-276
13. Shumway J.T., and Gambert S.R. Diabetic nephropathy-pathophysiology and management. Int Urol Nephrol 34 (2002) 257-264
14. Clark B. Biology of renal aging in humans. Adv Renal Replace Ther 7 (2000) 11-21
15. Spivak J.L. Serum immunoreactive erythropoietin in health and disease. J Perinat Med 23 (1995) 13-17
16. Ershler W.B., Sheng S., McKelvey J., Artz A.S., Denduluri N., Tecson J., et al. Serum erythropoietin and aging: a longitudinal analysis. J Am Geriatr Soc 53 (2005) 1360-1365
17. Artz A.S., Fergusson D., Drinka P.J., Gerald M., Bidenbender R., Lechich A.S., et al. Mechanisms of unexplained anemia in the nursing home. J Am Geriatr Soc 52 (2004) 423-427
18. Kario K., Matsuo T., Kodama K., Nakao K., and Asada R. Reduced erythropoietin secretion in senile anemia. Am J Hematol 41 (1992) 252-257
19. Kario K., Matsuo T., and Nakao K. Serum erythropoietin levels in the elderly. Gerontology 37 (1991) 345-348
20. Powers J.S., Krantz S.B., Collins J.C., Meurer K., Failinger A., Bucholz T., et al. Erythropoietin response to anemia as a function of age. J Am Geriatr Soc 39 (1991) 30-32
21. Artz A.S., Fergusson D., Drinka P.J., Gravenstein S., Lehich A., Silverstone F., et al. Prevalence of anemia in skilled-nursing home residents. Arch Gerontol Geriatr 39 (2004) 201-206
22. Landi F., Russo A., Danese P., Liperoti R., Barillaro C., Bernabei R., et al. Anemia status, hemoglobin concentration, and mortality in nursing home older residents. J Am Med Dir Assoc 8 (2007) 322-327
23. Robinson B., Artz A.S., Culleton B., Critchlow C., Sciarra A., and Audhya P. Prevalence of anemia in the nursing home: Contribution of chronic kidney disease. J Am Geriatr Soc 55 (2007) 1566-1570
24. Dumble M., Moore L., Chambers S.M., Geiger H., Van Zant G., Goodell M.A., et al. The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood 109 (2007) 1736-1742
25. Rossi D.J., Bryder D., and Weissman I.L. Hematopoietic stem cell aging: mechanism and consequence. Exp Gerontol 42 (2007) 385-390
26. Rossi D.J., Jamieson C.H., and Weissman I.L. Stems cells and the pathways to aging and cancer. Cell 132 (2008) 681-696
27. Rossi D.J., Seita J., Czechowicz A., Bhattacharya D., Bryder D., and Weissman I.L. Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle 6 (2007) 2371-2376
28. Shahidi NT: Androgens and erythropoiesis. N Engl J Med 289:72-80, 1073
29. Nissen C., Gratwohl A., and Speck B. Management of aplastic anemia. Eur J Haematol 46 (1991) 193-197
30. Schafer P.H., Gandhi A.K., Loveland M.A., Chen R.S., Man H.W., Schnetkamp P.P., et al. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs. J Pharmacol Exp Ther 305 (2003) 1222-1232
31. Schubert M., and Jockenhovel F. Late-onset hypogonadism in the aging male (LOH): Definition, diagnostic and clinical aspects. J Endocrinol Invest 28 suppl 3 (2005) 23-27
32. Voegeli T.A., Kurtz A., Grimm M.O., Effert P., and Eckardt K.U. Anemia under androgen deprivation: Influence of flutamide, cyproteroneacetate and orchiectomy on the erythropoietin system. Horm Metab Res 37 (2005) 3789-3793
33. Asbell S.O., Leon S.A., Tester W.J., Brereton H.D., Ago C.T., and Rotman M. Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy. Prostate 29 (1996) 243-248
34. Ferrucci L., Maggio M., Bandinelli S., Basaria S., Lauretani F., Ble A., et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 166 (2006) 1380-1388
35. Ershler W.B. Biological interactions of aging and anemia: A focus on cytokines. J Am Geriatr Soc 51 (2003) S18-S21
36. Moldawer L.L., Marano M.A., Wei H., Fong Y., Silen M.L., Kuo G., et al. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J 3 (1989) 1637-1643
37. Zamai L., Secchiero P., Pierpaoli S., Bassini A., Papa S., and Alnemri E.S. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood 95 (2000) 3716-3724
38. Sears D.A. Anemia of chronic disease. Med Clin North Am 76 (1992) 567-579
39. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev 16 (2002) 87-96
40. Andrews N.C. Anemia of inflammation: The cytokine-hepcidin link. J Clin Invest 113 (2004) 1251-1253
41. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102 (2003) 783-788
42. Ganz T. Hepcidin-A peptide hormone at the interface of innate immunity and iron metabolism. Curr Top Microbiol Immunol 306 (2006) 183-198
43. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113 (2004) 1271-1276
44. Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., et al. The origins of age-related proinflammatory state. Blood 105 (2005) 2294-2299
45. Hak A.E., Pols H.A., Stehouwer C.D., Meijer J., Kiliaan A.J., Hofman A., et al. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab 86 (2001) 4398-4405
46. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., and Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (1992) 2131-2135
47. Visser M., Pahor M., Taaffe D.R., Goodpaster B.H., Simonsick E.M., Newman A.B., et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J Gerontol A Biol Sci Med Sci 57 (2002) M326-M332
48. Ray P., Ghosh S.K., Zhang D.H., and Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: Inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 409 (1997) 79-85
49. Sun W.H., Keller E.T., Stebler B.S., and Ershler W.B. Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation. Biochem Biophys Res Commun 244 (1998) 691-695
50. Keller E.T., Chang C., and Ershler W.B. Inhibition of NFkappa B activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J Biol Chem 271 (1996) 26267-26275
51. Cooper A.C., Mikhail A., Lethbridge M.W., Kemeny D.M., and Macdougall I.C. Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol 14 (2003) 1776-1784
52. Macdougall I.C., and Cooper A.C. Erythropoietin resistance: The role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant 17 suppl (2002) 39-43
53. Bennett J.M., Kouides P.A., and Forman S.J. The myelodysplastic syndromes: Morphology, risk assessment, and clinical management (2002). Int J Hematol 76 suppl (2002) 228-238
54. Steensma D.P., and Bennett J.M. The myelodysplastic syndromes: Diagnosis and treatment. Mayo Clin Proc 81 (2006) 104-130
55. Joosten E., Pelemans W., Hiele M., Noyen J., Verhaeghe R., and Boogaerts M.A. Prevalence and causes of anaemia in a geriatric hospitalized population. Gerontology 38 (1992) 111-117
56. Agnihotri P., Telfer M., Butt Z., Jella A., Cella D., Kozma C.M., et al. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. J Am Geriatr Soc 55 (2007) 1557-1565
57. Ble A., Fink J.C., Woodman R.C., Klausner M.A., Windham B.G., and Guralnik J.M. Renal function, erythropoietin, and anemia of older persons: The InCHIANTI study. Arch Intern Med 165 (2005) 2222-2227